Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru)

International Journal of Medical Microbiology

Volumn 305, Issue 4-5, 2015, Pages 480-490

  Lluque, Angela ^a   Mosquito, Susan ^a   Gomes, Cláudia ^b   Riveros, Maribel ^a   Durand, David ^a   Tilley, Drake H ^c   Bernal, María ^c   Prada, Ana ^a   Ochoa, Theresa J ^a,d   Ruiz, Joaquim ^b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Peru   (Peru)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antimicrobial resistance; Autotransporters; Enterotoxins; Ipa; Shigella serotypes; Shigellosis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; INTEGRASE; INTEGRASE 1; INTEGRASE 2; NALIDIXIC ACID; NITROFURANTOIN; TETRACYCLINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; HUMAN; NONHUMAN; PERU; PERUVIAN; SEROTYPE; SEROTYPING; SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; URBAN AREA; CLASSIFICATION; DRUG EFFECTS; DYSENTERY, BACILLARY; GENETICS; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SUBURBAN POPULATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; PERU; POLYMERASE CHAIN REACTION; SEROGROUP; SHIGELLA; SUBURBAN POPULATION; VIRULENCE FACTORS;

EID: 84983094642     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.04.005     Document Type: Article

References (75)

1. Achard A., Guérin-Faublée V., Pichereau V., Villers C., Leclercq R. Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-Like gene. Antimicrob. Agents Chemother. 2008, 52:2767-2770.
2. Ahmed A.M., Furuta K., Shimomura K., Kasama Y., Shimamoto T. Genetic characterization of multidrug resistance in Shigella spp. from Japan. J. Med. Microbiol. 2006, 55:1685-1691.
3. Ashida H., Toyotome T., Nagai T., Sasakawa C. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol. Microbiol. 2007, 63:680-693.
4. Ashkenazi S., Levy I., Kazaronovski V., Samra Z. Growing antimicrobial resistance of Shigella isolates. J. Antimicrob. Chemother. 2003, 51:427-429.
5. Barrantes K., Achí R. Interacciones celulares en el proceso de invasión de Shigella sp. Rev. Panam Infectol. 2009, 11:56-61.
6. Bastos F.C., Loureiro E.C. Antimicrobial resistance of Shigella spp. isolated in the State of Pará, Brazil. Rev. Soc. Bras. Med. Trop. 2011, 44:607-610.
7. Boisen N., Ruiz-Perez F., Scheutz F., Krogfelt K.A., Nataro J.P. High prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am. J. Trop. Med. Hyg. 2009, 80:294-301.
8. Boumghar-Bourtchai L., Mariani-Kurkdjian P., Bingen E., Filliol I., Dhalluin A., Ifrane S.A., Weill F.X., Leclercq R. Macrolide-resistant Shigella sonnei. Emerg. Infect. Dis. 2008, 14:1297-1299.
9. Cabrera R., Ruiz J., Marco F., Oliveira I., Arroyo M., Aladueña A., Usera M.A., Jiménez de Anta M.T., Gascón J., Vila J. Mechanism of resistance to several antimicrobial agents in Salmonella clinical isolates causing traveler's diarrhea. Antimicrob. Agents Chemother. 2004, 48:3934-3939.
10. Clinical and Laboratory Standards Institute (CLSI). 2011. Performance standards for antimicrobial susceptibility testing: 21st informational supplement M100-S21 Clinical and Laboratory Standards Institute, Wayne, PA.
11. Day W.A., Fernández R.E., Maurelli A.T. Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp. Infect. Immun. 2001, 69:7471-7480.
12. Ecker L., Ochoa T.J., Vargas M., del Valle L.J., Ruiz J. Preferences of antibiotic use in children less than five in physicians working health centers of primary level in peri-urban areas of Lima. Peru. Rev. Peru. Med. Exp. Salud Publ. 2013, 30:181-189.
13. Efremova T.N., Gruzdeva I.G., Matveev I.V., Bozhokina E.S., Komissarchuk Y.Y., Fedorova Z.F., Khaitlina S.Y. Invasive characteristics of apathogenic Shigella flexneri 5a2c mutant obtained under the effect of furazolidone. Bull. Exp. Biol. Med. 2004, 137:479-482.
14. Erdman S.M., Buckner E.E., Hindler J.F. Options for treating resistant Shigella species infections in children. J. Pediatr. Pharmacol. Ther. 2008, 13:29-43.
15. Ejrnaes K., Sandvang D., Lundgren B., Ferry S., Holm S., Monsen T., Lundholm R., Frimodt-Moller N. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J. Clin. Microbiol. 2006, 44:1776-1781.
16. Fernández-Prada C.M., Venkatesan M.M., Franco A.A., Lanata C.F., Sack R.B., Hartman A.B., Spira W. Molecular epidemiology of Shigella flexneri in a diarrhoea-endemic area of Lima. Peru. Epidemiol. Infect. 2004, 132:303-316.
17. Ghosh A.S., Kar A.K., Kundu M. Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae. J. Antimicrob. Chemother. 1999, 43:195-201.
18. Gomes C., Pons M.J., Magallon-Tejada A., Durand D., Lluque A., Mosquito S., Riveros M., Mercado E., Prada A., Ochoa T.J., Ruiz J. In vitro development and analysis of Escherichia coli and Shigella boydii azithromycin-resistant mutants. Microb. Drug Resist. 2013, 19:88-93.
19. Gomes C., Ruiz L., Pons M.J., Ochoa T.J., Ruiz J. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates. Trans. R. Soc. Trop. Med. Hyg. 2013, 107:545-549.
20. Hamilton-West M., Prado J., Hormazábal J.C., Lagos R., Benadof D., Mendoza C., Elgueta A., Tapia C., Cifuentes M., Alvarez I., Hernández M. Epidemiología clínica y molecular de las infecciones por Shigella spp. en niños de la Región Metropolitana durante el verano 2004-2005. Rev. Med. Chil. 2007, 135:1388-1396.
21. Howie R.L., Folster J.P., Bowen A., Barzilay E.J., Whichard J.M. Reduced azithromycin susceptibility in Shigella sonnei United States. Microb. Drug Resist. 2010, 16:245-248.
22. Johnson J.R., O'Bryan T.T., Low D.A., Ling G., Delavari P., Fasching C., Russo T.A., Carlino U., Stell A.L. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III. Infect. Immun. 2000, 68:3327-3336.
23. Kosek M., Yori P.P., Pan W.K., Olortegui M.P., Gilman R.H., Perez J., Chavez C.B., Sanchez G.M., Burga R., Hall E. Epidemiology of highly endemic multiply antibiotic-resistant Shigellosis in children in the Peruvian Amazon. Pediatrics 2008, 122:541-549.
24. Lanata C.F., Fischer-Walker C.L., Olascoaga A.C., Torres C.X., Aryee M.J., Black R.E. Child Health Epidemiology Reference Group of the World Health Organization and UNICEF. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One 2013, 8:e72788.
25. Li Y., Cao B., Liu B., Liu D., Gao Q., Peng X., Wu J., Bastin D.A., Feng L., Wang L. Molecular detection of all 34 distinct O-antigen forms of Shigella. J. Med. Microbiol. 2009, 58:69-81.
26. Lima A.A., Lima N.L., Pinho M.C., Barros Juñior E.A., Teixeira M.J., Martins M.C., Guerrant R.L. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988-1993. Antimicrob. Agents Chemother. 1995, 39:256-259.
27. Liu J., Keelan P., Bennett P.M., Enne V.I. Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli. J. Antimicrob. Chemother. 2009, 63:423-426.
28. Livio S., Strockbine N.A., Panchalingam S., Tennant S.M., Barry E.M., Marohn M.E., Antonio M., Hossain A., Mandomando I., Ochieng J.B., Oundo J.O., Qureshi S., Ramamurthy T., Tamboura B., Adegbola R.A., Hossain M.J., Saha D., Sen S., Faruque A.S., Alonso P.L., Breiman R.F., Zaidi A.K., Sur D., Sow S.O., Berkeley L.Y., O'Reilly C.E., Mintz E.D., Biswas K., Cohen D., Farag T.H., Nasrin D., Wu Y., Blackwelder W.C., Kotloff K.L., Nataro J.P., Levine M.M. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin. Infect. Dis. 2014, 59:933-941.
29. Mamishi S., Mashoori N., Mahboobi N., Pour Akbari B. Increasing resistance to nalidixic acid in Shigella subgroups in a comparative study between 2001-2003 and 2004-2006. Singapore Med. J. 2009, 50:791-793.
30. Mandomando I., Jaintilal D., Pons M.J., Vallès X., Espasa M., Mensa L., Sigaúque B., Sanz S., Sacarlal J., Macete E., Abacassamo F., Alonso P.L., Ruiz J. Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique. Antimicrob. Agents Chemother. 2009, 53:2450-2454.
31. Maurelli A.T., Fernández R.E., Bloch C.A., Rode C.K., Fasano A. Black holes and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. USA 1998, 95:3943-3948.
32. Mensa L., Marco F., Vila J., Gascón J., Ruiz J. Quinolone-resistance in Shigella spp. causing traveller's diarrhoea. Clin. Microbiol. Infect. 2008, 14:279-281.
33. MINSA (Ministerio de Salud) - Dirección General de Salud de las Personas. 2006. Guía de práctica clínica. Diarrea disentérica en la niña y el niño. In: Guía de práctica clínica para la atención de las patologías más frecuentes y cuidados esenciales del niño y la niña. Ministerio de Salud, Lima (Peru).
34. Mosquito S., Ruiz J., Pons M.J., Durand D., Barletta F., Ochoa T.J. Molecular mechanisms of antibiotic resistance in diarrhoeagenic Escherichia coli isolated from children. Int. J. Antimicrob. Agents 2012, 40:544-548.
35. Nakata N., Tobe T., Fukuda I., Suzuki T., Komatsu K., Yoshikawa M., Sasakawa C. The absence of a surface protease, OmpT, determines the intercellular spreading ability of Shigella: the relationship between the ompT and kcpA loci. Mol. Microbiol. 1993, 9:459-468.
36. Navia M.M., Capitano L., Ruiz J., Vargas M., Urassa H., Schellemberg D., Gascón J., Vila J. Typing and characterization of the mechanisms of resistance in Shigella sp. isolated from faeces of children in Ifakara (Tanzania). J. Clin. Microb. 1999, 37:3113-3117.
37. Navia M.M., Gascón J., Vila J. Analysis of the mechanisms of resistance to several antimicrobial agents in Shigella spp. causing travellers' diarrhoea. Clin. Microbiol. Infect. 2005, 11:1044-1047.
38. Nguyen M.C.P., Woerther P.L., Bouvet M., Andremont A., Leclercq R., Canu A. Escherichia coli as reservoir for macrolide resistance genes. Emerg. Infect. Dis. 2009, 15:1648-1650.
39. Niebuhr K., Jouihri N., Allaoui A., Gounon P., Sansonetti P.J., Parsot C. IpgD, a protein secreted by the type III secretion machinery of Shigella flexneri, is chaperoned by IpgE and implicated in entry focus formation. Mol. Microbiol. 2000, 38:8-19.
40. Niyogi S.W. Shigellosis. J. Microbiol. 2005, 43:133-143.
41. Noriega F.R., Liao F.M., Formal S.B., Fasano A., Levine M.M. Prevalence of Shigella enterotoxin among Shigella clinical isolates of diverse serotypes. J. Infect. Dis. 1995, 172:1408-1410.
42. Ochoa T.J., Chea-Woo E., Baiocchi N., Pecho I., Campos M., Prada A., Valdiviezo G., Lluque A., Lai D., Cleary T.G. Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J. Pediatr. 2013, 162:349-356.
43. Ochoa T.J., Ruiz J., Molina M., Del Valle L.J., Vargas M., Gil A.I., Ecker L., Barletta F., Hall E., Cleary T.G., Lanata C.F. High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am. J. Trop. Med. Hyg. 2009, 8:296-301.
44. Pan J.C., Ye R., Meng D.M., Zhang W., Wang H.Q., Liu K.Z. Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri. J. Antimicrob. Chemother. 2006, 58:288-296.
45. Peirano G., Agersø Y., Aarestrup F.M., Dos Prazeres Rodrigues D. Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J. Antimicrob. Chemother. 2005, 55:301-305.
46. Peirano G., Souza F.S., Rodrigues D.P. Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil. Mem. Inst. Oswaldo Cruz 2006, 101:245-250.
47. Pons M.J., Gomes C., Martínez-Puchol S., Ruiz L., Mensa L., Vila J., Gascón J., Ruiz J. Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995-2010): a retrospective analysis. Travel Med. Infect. Dis. 2013, 11:315-319.
48. Pons M.J., Mosquito S.G., Ochoa T.J., Vargas M., Lluque A., Molina M., Gil A.I., Ecker L., Barletta F., Lanata C.F., del Valle L.J., Ruiz J. Niveles de resistencia a quinolonas y otros antimicrobianos en cepas de Escherichia coli comensales en niños de la zona periurbana de Lima. Perú. Rev. Peru. Med. Exp. Salud Publ. 2012, 29:82-86.
49. Pons M.J., Vubil D., Guiral E., Jaintilal D., Fraile O., Soto S.M., Sigauque B., Nhampossa T., Aide P., Alonso P.L., Vila J., Mandomando I., Ruiz J. Characterisation of extended spectrum β-Lactamases among Klebsiella pneumoniae isolates causing bacteraemia and urinary tract infection in Mozambique. J. Global Antimicrob. Resist. 2015, 3:19-25.
50. Retsema J., Girald A., Schelkly W., Manousos M., Anderson M., Bright G., Borovoy R., Brennan L., Mason R. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob. Agents Chemother. 1987, 31:1939-1947.
51. Rolfo F., Marin G.H., Silberman M., Pattin J., Giugnio S., Gatti B., Bettiol M., Rigoni A. Epidemiological study of shigellosis in an urban area of Argentina. J. Infect Dev. Ctries. 2012, 6:324-328.
52. Ruiz J., Navia M.M., Vila J., Gascón J. Prevalence of the sat gene among clinical isolates of Shigella spp. causing travelers' diarrhea: geographical and specific differences. J. Clin. Microbiol. 2002, 40:1565-1566.
53. Saenz Y., Briñas L., Domínguez E., Ruiz J., Zarazaga M., Vila J., Torres C. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob. Agents Chemother. 2004, 48:3996-4001.
54. Sansonetti P.J., Kopecko D.J., Formal S.B. Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. Infect. Immun. 1981, 34:75-83.
55. Sasakawa C., Kamata K., Sakai T., Murayama S.Y., Makino S., Yoshikawa M. Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and congo red binding activity in Shigella flexneri. Infect. Immun. 1986, 51:470-475.
56. Sharma A., Singh S.K., Bajpai D. Phenotypic and genotypic characterization of Shigella spp. with reference to its virulence genes and antibiogram analysis from river Narmada. Microbiol. Res. 2010, 165:33-42.
57. Schroeder G.N., Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 2008, 21:134-156.
58. Sire J.M., Macondo E.A., Perrier-Gros-Claude J.D., Siby T., Bahsoun I., Seck A., Garin B. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006). Jpn. J. Infect. Dis. 2008, 61:307-309.
59. Sjölund Karlsson M., Bowen A., Reporter R., Folster J.P., Grass J.E., Howie R.L., Taylor J., Whichard J.M. Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. Antimicrob. Agents Chemother. 2013, 57:1559-1560.
60. Steele D., Riddle M., Van de Verg M., Bourgeois L. Vaccines for enteric diseases: a meeting summary Expert Rev. Vaccines 2012, 11:407-409.
61. Suárez M.E., Carvajal L., Culasso C. Resistencia de Shigella spp. a los antimicrobianos en Cordoba, Argentina, durante el periodo 1990-1997. Rev. Panam. Salud Publica 2000, 7:113-117.
62. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 1996, 40:2562-2566.
63. Szijártó V., Hunyadi-Gulyás E., Emody L., Pál T., Nagy G. Cross-protection provided by live Shigella mutants lacking major antigens. Int. J. Med. Microbiol. 2013, 303:167-175.
64. Tajbakhsh M., García Migura L., Rahbar M., Svendsen C.A., Mohammadzadeh M., Zali M.R., Aarestrup F.M., Hendriksen R.S. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem?. J. Antimicrob. Chemother. 2012, 67:1128-1133.
65. Thong K.L., Hoe S.L., Puthucheary S.D., Yasin R.M. Detection of virulence genes in Malaysian Shigella species by multiplex PCR assay. BMC Infect. 2005, 5:8.
66. Toma C., Lu Y., Higa N., Nakasone N., Chinen I., Baschkier A., Rivas M., Iwanaga M. Multiplex PCR assay for identification of human diarrheagenic Escherichia coli. J. Clin. Microbiol. 2003, 41:2669-2671.
67. Toro C.S., Farfán M., Contreras I., Flores O., Navarro N., Mora G.C., Prado V. Genetic analysis of antibiotic-resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children. Epidemiol. Infect. 2005, 133:81-86.
68. Vargas M., Gascon J., Jimenez de Anta M.T., Vila J. Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveller's diarrhoea. J. Clin. Microbiol. 1999, 27:3608-3611.
69. Vila J., Navia M., Ruiz J., Casals C. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived ß-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 1997, 41:2757-2759.
70. Vila J., Vargas M., Henderson I.R., Gascón J., Nataro J.P. Enteroaggregative Escherichia coli virulence factors in traveler's diarrhea strains. J. Infect. Dis. 2000, 182:1780-1783.
71. Villalobo E., Torres A. PCR for detection of Shigella spp. in mayonnaise. Appl. Environ. Microbiol. 1998, 64:1242-1245.
72. Whiteway J., Koziarz P., Veall J., Sandhu N., Kumar P., Hoecher B., Lamber I.B. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli. J. Bacteriol. 1998, 180:5529-5539.
73. Yah S.C. Plasmid-encoded multidrug resistance: a case study of Salmonella and Shigella from enteric diarrhea sources among humans. Biol. Res. 2010, 43:141-148.
74. Yang F., Yang J., Zhang X., Chen L., Jiang Y., Yan Y., Tang X., Wang J., Xiong Z., Dong J., Xue Y., Zhu Y., Xu X., Sun L., Chen S., Nie H., Peng J., Xu J., Wang Y., Yuan Z., Wen Y., Yao Z., Shen Y., Qiang B., Hou Y., Yu J., Jin Q. Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res. 2005, 33:6445-6458.
75. Zhu J.Y., Duan G.C., Yang H.Y., Fan Q.T., Xi Y.L. Atypical class 1 integron coexists with class 1 and class 2 integrons in multi-drug resistant Shigella flexneri isolates from China. Curr. Microbiol. 2011, 62:802-806.